ND PHARMA & BIOTECH LTD

	Page
Balance Sheet	1
Notes to the Financial Statements	2

Registered number: 08273797

		2025		2024
	Notes	£	£	£	£
FIXED ASSETS
Investments	4		1,549,225		1,549,225

			1,549,225		1,549,225
CURRENT ASSETS
Debtors	5	210,002,660		210,002,660

		210,002,660		210,002,660
Creditors: Amounts Falling Due Within One Year	6	(312,157 )		(310,855 )

NET CURRENT ASSETS (LIABILITIES)			209,690,503		209,691,805

TOTAL ASSETS LESS CURRENT LIABILITIES			211,239,728		211,241,030

NET ASSETS			211,239,728		211,241,030

CAPITAL AND RESERVES
Called up share capital	7		210,000,100		210,000,100
Profit and Loss Account			1,239,628		1,240,930

SHAREHOLDERS' FUNDS			211,239,728		211,241,030

For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

On behalf of the board

Mr Jose Manuel Lopez Perez

Director

30/07/2026

The notes on page 2 form part of these financial statements.

1. General Information

ND PHARMA & BIOTECH LTD is a private company, limited by shares, incorporated in England & Wales, registered number 08273797 . The registered office is 87 Chancery Lane, Third Floor, A&T, London, WC2A 1ET.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

3. Average Number of Employees

Average number of employees, including directors, during the year was: NIL (2024: NIL)

4. Investments

	Unlisted
	£
Cost or Valuation
As at 1 November 2024	1,549,225

As at 31 October 2025	1,549,225

Provision
As at 1 November 2024	-

As at 31 October 2025	-

Net Book Value
As at 31 October 2025	1,549,225

As at 1 November 2024	1,549,225

5. Debtors

	2025	2024
	£	£
Due within one year
VAT	2,560	2,560
Called up share capital not paid	210,000,100	210,000,100

	210,002,660	210,002,660

6. Creditors: Amounts Falling Due Within One Year

	2025	2024
	£	£
Amounts owed to related parties	312,157	310,855

7. Share Capital

	2025	2024
	£	£
Called Up Share Capital not Paid	210,000,100	210,000,100

Amount of Allotted, Called Up Share Capital	210,000,100	210,000,100